Advertisement

Wie wirkt „Ritalin“?

  • Hans-Reinhard SchmidtEmail author
Chapter

Zusammenfassung

Die in Deutschland unter das Betäubungsmittelgesetz fallenden Methylphenidatpsychopharmaka, die bei ADHS verschrieben werden, wirken trotz tausender Forschungsstudien auf bisher noch nicht vollständig bekannte Weise auf das meist noch in Entwicklung begriffene kindliche Gehirn. Wie alle Amphetamine hält Methylphenidat wach, schärft die Sinne und die Aufmerksamkeit, verbessert die Selbstkontrolle und macht ruhig und gefasst, und zwar nicht nur bei ADHS, sondern allgemein. „Ritalin“ verändert das Gehirn. Es gibt keine seriösen Hinweise auf die Langzeitsicherheit der Medikamente.

Literatur

  1. Arznei-Telegramm. (2005). http://www.arznei-telegramm.de/register/0504044.pdf. Zugegriffen: 10. Juni 2005.
  2. Bangs, M. E., et al. (2008). Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. Journal of the American Academy of Child and Adolescent Psychiatry.  https://doi.org/10.1097/chi.0b013e31815d88b2.CrossRefGoogle Scholar
  3. Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003). Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics, 111(1), 97–109.CrossRefGoogle Scholar
  4. Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009). Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics, 124(1), 71–78.CrossRefGoogle Scholar
  5. Brandon, C. L., & Steiner, H. (2003). Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. European Journal of Neuroscience, 18(6), 1584–1592.CrossRefGoogle Scholar
  6. Brandon, C. L., Marinelli, M., & White, F. J. (2003). Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biological Psychiatry, 54(12), 1338–1344.CrossRefGoogle Scholar
  7. Breggin, P. R. (1999). Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk & Safety in Medicine, 12,3–35.Google Scholar
  8. Breggin, P. R. (2002). The Ritalin Fact Book. What your doctor won´t tell you about ADHD and stimulant drugs. New York: Perseus.Google Scholar
  9. Breggin, P. R., & Cohen, D. (2007). Your drug may be your problem. How and why to stop taking psychiatric medications. http://www.grapinar.com.br/gaia/eng/mental/psydrug/psychiatry_drug_problem.pdf. Zugegriffen: 8. Sept. 2018.
  10. Carlezon, W. A., Jr., Mague, S. D., & Andersen, S. L. (2003). Enduring behavioral effects of early exposure to methylphenidate in rats. Biological Psychiatry, 54(12), 1330–1337.CrossRefGoogle Scholar
  11. Charles, L., & Schain, R. (1981). A four-year follow-up study of the effects of methylphenidate on the behavior and academic achievement of hyperactive children. Journal of Abnormal Child Psychology, 9(4), 495–505.CrossRefGoogle Scholar
  12. Cherland, E., & Fitzpatrick, R. (1999). Psychotic side effects of psychostimulants: A 5-year review. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 44(8), 811–813.CrossRefGoogle Scholar
  13. Deutsches Ärzteblatt. (16. Juni 2009). ADHS: FDA untersucht plötzliche Todesfälle unter Ritalin. http://www.aerzteblatt.de/nachrichten/36977/ADHS_FDA_untersucht_ploetzliche_Todesfaelle_unter_Ritalin.htm. Zugegriffen: 31. Juli 2018.
  14. Drug Effectiveness Review Project. (2003). http://www.ohsu.edu/drugeffectiveness/. Zugegriffen: 31. Juli 2018.
  15. El-Zein, R. A., Abdel-Rahman, S. Z., Hay, M. J., Lopez, M. S., Bondy, M. L., Morris, D. L., et al. (2005). Cytogenetic effects in children treated with methylphenidate. Cancer Letters, 230(2), 284–291.CrossRefGoogle Scholar
  16. Feuer, A. J., et al. (2016). Association of stimulant medication use with bone mass in children and adolescents with attention-deficit/hyperactivity disorder. JAMA Pediatrics.  https://doi.org/10.1001/jamapediatrics.2016.2804.CrossRefGoogle Scholar
  17. Furman, L. M. (2003). Attention-deficit/hyperactivity disorder treatment and later drug use. Pediatrics, 112(6), 1459–1460.CrossRefGoogle Scholar
  18. Gatley, S. J., Volkow, N. D., Gifford, A. N., Fowler, J. S., Dewey, S. L., Ding, Y. S., et al. (1999). Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology, 146(1), 93–100.CrossRefGoogle Scholar
  19. Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., et al. (2009). Sudden death and use of stimulant medications in youths. The American Journal of Psychiatry, 166(9), 992–1001.CrossRefGoogle Scholar
  20. Greenhill, L. L., Posner, K., Vaughan, B. S., & Kratochvil, C. J. (2008). Attention deficit hyperactivity disorder in preschool children. Child and Adolescent Psychiatric Clinics of North America, 17(2), 347–366.CrossRefGoogle Scholar
  21. Grund, T., et al. (2006). Influence of methylphenidate on brain development – An update of recent animal experiments. Behavioral and Brain Functions 2, 2. https://behavioralandbrainfunctions.biomedcentral.com/articles/10.1186/1744-9081-2-2. Zugegriffen: 8. Sept. 2018.
  22. Holtmann, M., Kaina, B., & Poustka, F. (2006). Zytogenetische Veränderungen durch Methylphenidat? Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 34(3), 215–220.CrossRefGoogle Scholar
  23. Hoogman, M., et al. (2017). Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis. Lancet Psychiatry.  https://doi.org/10.1016/s2215-0366(17)30049-4.CrossRefGoogle Scholar
  24. Hüther, G. (2002). Die Folgen traumatischer Kindheitserfahrungen für die weitere Hirnentwicklung. Arbeitsgemeinschaft für Sozialberatung und Psychotherapie. http://www.agsp.de/html/a34.html. Zugegriffen: 8. Sept. 2018.
  25. Iversen, L. (2009). Speed, Ecstasy, Ritalin. Amphetamine – Theorie und Praxis. Bern: Huber.Google Scholar
  26. Kenagy, D. N., Bird, C. T., Webber, C. M., & Fischer, J. H. (2004). Dextroamphetamine use during B-2 combat missions. Aviation, Space, and Environmental Medicine, 75,381–386.Google Scholar
  27. Krause, K.-H., Dresel, St., & Krause, J. (2000). Neurobiologie der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Psycho, 26.Google Scholar
  28. Lisska, M. C., & Rivkees, S. A. (2003). Daily methylphenidate use slows the growth of children: a community based study. Journal of Pediatric Endocrinology & Metabolism, 16(5), 711–718.CrossRefGoogle Scholar
  29. Molina, B. S., et al. (2009). MTA at 8 Years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry.  https://doi.org/10.1097/chi.0b013e31819c23d0.CrossRefGoogle Scholar
  30. Moll, G. H., Heinrich, H., & Rothenberger, A. (2003). Methylphenidate and intracortical excitability: Opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatrica Scandinavica, 107(1), 69–72.CrossRefGoogle Scholar
  31. Moll, G. H., Hause, S., Ruther, E., Rothenberger, A., & Huether, G. (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. Journal of Child and Adolescent Psychopharmacology, 11(1), 15–24.CrossRefGoogle Scholar
  32. Rapoport, J. L., & Inoff-Germain, G. (2002). Responses to methylphenidate in attention-deficit/hyperactivity disorder and normal children: Update 2002. Journal of Attention Disorders, 6(Suppl 1), 57–60.CrossRefGoogle Scholar
  33. Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978). Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science, 199(4328), 560–563.CrossRefGoogle Scholar
  34. Ricaurte, G. A., Mechan, A. O., Yuan, J., Hatzidimitriou, G., Xie, T., Mayne, A. H., et al. (2005). Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. The Journal of Pharmacology and Experimental Therapeutics, 315(1), 91–98.CrossRefGoogle Scholar
  35. Satterfield, J. H., Hoppe, C. M., & Schell, A. M. (1982). A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys. The American Journal of Psychiatry, 139(6), 795–798.CrossRefGoogle Scholar
  36. Smith, D. E., & Fisher, G. M. (1970). An analysis of 310 cases of acute-high-dose metamphetamine toxicity in Haight-Ashbury. Clinical Toxicology, 3,117–124.CrossRefGoogle Scholar
  37. Storeboe, O. J. et al. (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Systematic Review.Google Scholar
  38. Vastag, B. (2001). Pay attention: Ritalin acts much like cocaine. JAMA, 286(8), 905–906.CrossRefGoogle Scholar
  39. Volkow, N. D. (2006). Stimulant medications: How to minimize their reinforcing effects? American Journal of Psychiatry, 163,359–361.CrossRefGoogle Scholar
  40. Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002). Mechanism of action of methylphenidate: Insights from PET imaging studies. Journal of Attention Disorders, 1(6 Suppl), 31–43.CrossRefGoogle Scholar
  41. Volkow, N. D., Wang, G. J., Fowler, J. S., & Ding, Y. S. (2005). Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biological Psychiatry, 57(11), 1410–1415.CrossRefGoogle Scholar
  42. Walitza, S., Werner, B., Romanos, M., Warnke, A., Gerlach, M., & Stopper, H. (2007). Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder? Environmental Health Perspectives, 115(6).CrossRefGoogle Scholar
  43. Wang, G. J., Volkow, N. D., Fowler J. S., Ferrieri, R., Schlyer, D. J., Alexoff, D., Pappas, N., Lieberman, J., King. P, Warner, D., et al. (1994). Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sciences, 54(9), PL143–PL146.CrossRefGoogle Scholar
  44. Zhang, H. Y., Du, M. L., Zhuang, S. Q., & Liu, M. N. (2005). Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder. Zhonghua Er Ke Za Zhi, 43(10), 723–727.Google Scholar

Copyright information

© Springer Fachmedien Wiesbaden GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Praxis für PsychotherapieBornheimDeutschland

Personalised recommendations